Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency von Inbal, Aida, Oldenburg, Johannes, Carcao, Manuel, Rosholm, Anders, Tehranchi, Ramin, Nugent, Diane

Volltext

A New Statistical Test Based on the WR for Detecting Offsets in GPS Experiment von Tehranchi, Ramin, Moghtased‐Azar, Khosro, Safari, Abdolreza

Volltext

Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study von Tehranchi, Ramin, Pettersson, Jonas, Melgaard, Anita E., Seitz, Friedeborg, Valeur, Anders, Maarbjerg, Stine Just

Volltext

The WHO classification of MDS does make a difference von Howe, Robert B., Porwit-MacDonald, Anna, Wanat, Robert, Tehranchi, Ramin, Hellström-Lindberg, Eva

Volltext

Defining the Ideal Injection Techniques When Using 5-mm Needles in Children and Adults von Hofman, Paul Leslie, Derraik, José Guilherme Behrensdorf, Pinto, Teresa Elizabeth, Tregurtha, Sheryl, Faherty, Ann, Peart, Jane Michele, Drury, Paul Leslie, Robinson, Elizabeth, Tehranchi, Ramin, Donsmark, Morten, Cutfield, Wayne Stephen

Volltext

Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors von Tehranchi, Ramin, Fadeel, Bengt, Forsblom, Ann-Mari, Christensson, Birger, Samuelsson, Jan, Zhivotovsky, Boris, Hellstrom-Lindberg, Eva

Volltext

Dasiglucagon: A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia Results of Phase 3 Randomized Double-Blind Clinical Trial von Pieber, Thomas R, Aronson, Ronnie, Hövelmann, Ulrike, Willard, Julie, Plum-Mörschel, Leona, Knudsen, Kim M, Bandak, Benedikte, Tehranchi, Ramin

Volltext

Dasiglucagon-A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial von Pieber, Thomas R, Aronson, Ronnie, Hövelmann, Ulrike, Willard, Julie, Plum-Mörschel, Leona, Knudsen, Kim M, Bandak, Benedikte, Tehranchi, Ramin

Volltext

Antiapoptotic Role of Growth Factors in the Myelodysplastic Syndromes: Concordance Between In vitro and In vivo Observations von TEHRANCHI, Ramin, FADEEL, Bengt, ZHIVOTOVSKY, Boris, HELLSTRÖM-LINDBERG, Eva, SCHMIDT-MENDE, Jan, FORSBLOM, Ann-Mari, EMANUELSSON, Emma, JADERSTEN, Martin, CHRISTENSSON, Birger, HAST, Robert, HOWE, Robert B, SAMUELSSON, Jan

Volltext

Ready-to-use Dasiglucagon Injection as a Rapid and Effective Treatment for Severe Hypoglycemia von Pieber, Thomas, Tehranchi, Ramin, Hövelmann, Ulrike, Willard, Julie, Plum-Moerschel, Leona, Kendall, David, Aronson, Ronnie

Volltext

Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission von Tehranchi, Ramin, Woll, Petter S, Anderson, Kristina, Buza-Vidas, Natalija, Mizukami, Takuo, Mead, Adam J, Åstrand-Grundström, Ingbritt, Strömbeck, Bodil, Horvat, Andrea, Ferry, Helen, Dhanda, Rakesh Singh, Hast, Robert, Rydén, Tobias, Vyas, Paresh, Göhring, Gudrun, Schlegelberger, Brigitte, Johansson, Bertil, Hellström-Lindberg, Eva, List, Alan, Nilsson, Lars, Jacobsen, Sten Eirik W

Volltext

Dasiglucagon, a next‐generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double‐blind trial von Bailey, Timothy S., Willard, Julie, Klaff, Leslie J., Yager Stone, Jenine, Melgaard, Anita, Tehranchi, Ramin

Volltext

Dasiglucagon—A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial von Pieber, Thomas R., Aronson, Ronnie, Hövelmann, Ulrike, Willard, Julie, Plum-Mörschel, Leona, Knudsen, Kim M., Bandak, Benedikte, Tehranchi, Ramin

Volltext

286-OR: Phase 3 Results for Dasiglucagon as a Fast and Effective Treatment for Severe Hypoglycemia von PIEBER, THOMAS R., HOEVELMANN, ULRIKE, WILLARD, JULIE, PLUM-MOERSCHEL, LEONA, MOURITZEN, ULRIK, TEHRANCHI, RAMIN, ARONSON, RONNIE

Volltext

Immunogenicity of the Novel Glucagon Analogue Dasiglucagon: Results of a Dedicated Immunogenicity Trial in Type 1 Diabetes von Pieber, Thomas R, Ajala, Olubukola, Steen, Oren, Dahl, Dominik, Hansen, Lone Eske, Tehranchi, Ramin

Volltext

Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomize... von Battelino, Tadej, Tehranchi, Ramin, Bailey, Timothy, Dovc, Klemen, Melgaard, Anita, Yager Stone, Jenine, Woerner, Stephanie, von dem Berge, Thekla, DiMeglio, Linda, Danne, Thomas

Volltext

356-P: Population Pharmacokinetic Modeling of Dasiglucagon in Subjects with Type 1 Diabetes Mellitus von KNUDSEN, CARSTEN B., VALEUR, ANDERS H., MAARBJERG, STINE JUST, TEHRANCHI, RAMIN, DIDERICHSEN, PAUL MATTHIAS, WITJES, HAN

Volltext

137-OR: Dasiglucagon Ready-to-Use Autoinjector Is More Reliably and Quickly Administered than Glucagon Emergency Kit (GEK) von BAILEY, N. CELESTE, DIMSITS, JEANNETT, TEHRANCHI, RAMIN, KENDALL, DAVID M., BAILEY, TIMOTHY S.

Volltext

The Next-generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery From Hypoglycemia Across Subgroups von Battelino, Tadej, Bailey, Timothy, Tehranchi, Ramin, Klaff, Leslie, Pieber, Thomas R., Hövelman, Ulrike, Plum-Mörschel, Leona, Melgaard, Anita E., Aronson, Ronnie, DiMeglio, Linda A., Danne, Thomas, Kendall, David

Volltext

An alternative method for non-negative estimation of variance components von Moghtased-Azar, Khosro, Tehranchi, Ramin, Amiri-Simkooei, Ali Reza

Volltext